Quality of life after surgical treatment of mitral heart disease

Cover Page

Cite item

Full Text

Abstract

Aim. To evaluate long-term quality of life (QOL) of patients after surgical treatment of mitral valve disease depending on the types of surgical intervention, to identify predictors of a lower QOL after surgery.

Material and methods. A single-center retrospective study involved 107 patients after isolated correction of primary non-ischemic mitral valve (MV) pathology, who were operated on from 2009 to 2016, and analyzed their long-term QOL. The follow-up period was from 2 to 6 years. 2 groups of patients were formed: the 1st group (n=60) – patients who underwent mitral valve replacement (MVR); the 2nd group (n=47) – patients who underwent mitral valve repair (MVRep). There were no statistically significant differences between the main clinical and demographic characteristics in reference to the groups. The SF-36 questionnaire was used for studying QOL.

Results. The indicators of QOL approach the average population levels in both groups. In group MVRep Physical Functioning – PF (p=0.02 and 0.01), Bodily Pain – BP (p=0.04), Vitality – VT (p=0.01) and Social Functioning – SF (p=0.001) are higher. There are improvements in physical and mental health components after surgery. Mental and physical components are lower than in the normal population but they don’t go beyond average population’s indicators. Mental health in the MVRep group is better than in the MVR group (p=0.01). Female gender, dilatation of the left atrium (every 1 mm before surgery), older age (every year) increased the probability of lower QOL in the long term by 84, 11 and 8% respectively.

Conclusion. Long-term QOL of patients after surgical treatment of mitral valve disease improves both after valve repair and after valve replacement. After MVRep Physical Functioning, Bodily Pain, Vitality and Social Functioning indicators are higher. There are improvements in physical and mental health components. Psychological component of health is higher in patients in the MVRep-group. Female gender, dilatation of the left atrium, older age increase the probability of lower QOL in the long term after mitral valve surgery.

About the authors

Vladlen V. Bazylev

Federal Center of Cardiovascular Surgery

Email: galana2004@mail.ru
ORCID iD: 0000-0001-6089-9722

D. Sci. (Med.), Prof.

Russian Federation, Penza

Evgeniy V. Nemchenko

Federal Center of Cardiovascular Surgery

Email: galana2004@mail.ru

D. Sci. (Med.)

Russian Federation, Penza

Galina N. Abramova

Federal Center of Cardiovascular Surgery

Author for correspondence.
Email: galana2004@mail.ru
ORCID iD: 0000-0003-0373-9938

Cand. Sci. (Med.)

Russian Federation, Penza

Tаtyana V. Kanaeva

Federal Center of Cardiovascular Surgery

Email: galana2004@mail.ru
ORCID iD: 0000-0003-3948-560X

Cand. Sci. (Med.)

Russian Federation, Penza

Vаdim A. Karnakhin

Federal Center of Cardiovascular Surgery

Email: galana2004@mail.ru
ORCID iD: 0000-0002-1815-7116

cardiovascular surgeon

Russian Federation, Penza

References

  1. Ung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol 2014; 30: 962–70.
  2. Gammie JS, Sheng S, Griffith BP et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2009; 87: 1431–7.
  3. Vassileva CM, Mishkel G, McNeely C et al. Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries. Circulation 2013; 127: 1870–6.
  4. Geldenhuys A, Koshy JJ, Human PA et al. Rheumatic mitral repair versus replacement in a threshold country: the impact of commissural fusion. J Heart Valve Dis 2012; 21: 424–32.
  5. Baumgartner H, Falk V, Bax JJ et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38 (36): 2739–91. doi: 10.1093/eurheartj/ehx391
  6. Базылев В.В., Немченко Е.В., Абрамова Г.Н., Карнахин В.А. Качество жизни у больных после хирургического лечения фибрилляции предсердий. CardioСоматика. 2017; 8 (3): 22–8. [Bazylev V.V., Nemchenko E.V., Abramova G.N., Karnakhin V.A. Quality of life in patients after surgical treatment of atrial fibrillation. Cardiosomatics. 2017; 8 (3): 22–8 (in Russian).]
  7. Базылев В.В., Россейкин Е.В., Микуляк А.И. и др. Динамика качества жизни пациентов с аортальным стенозом после протезирования биологическим или механическим протезом. Кардиология. 2018; 58 (9): 31–6. [Bazylev V.V., Rosseikin E.V., Mikuliak A.I. et al. Dinamika kachestva zhizni patsientov s aortal’nym stenozom posle protezirovaniia biologicheskim ili mekhanicheskim protezom. Kardiologiia. 2018; 58 (9): 31–6 (in Russian).]
  8. Базылев В.В., Шутов Д.Б., Асташкин А.Ф., Карнахин В.А. Разработка и внедрение методики проведения исследования качества медицинской помощи после кардиохирургического лечения с использованием опросника SF-36. Вестн. Росздравнадзора. 2016; 6: 67–73. [Bazylev V.V., Shutov D.B., Astashkin A.F., Karnakhin V.A. Razrabotka i vnedrenie metodiki provedeniia issledovaniia kachestva meditsinskoi pomoshchi posle kardiokhirurgicheskogo lecheniia s ispol’zovaniem oprosnika SF-36. Vestn. Roszdravnadzora. 2016; 6: 67–73 (in Russian).]
  9. Buzzatti N, Maisano F, Latib A et al. Comparison of outcomes of percutaneous MitraClip versus surgical repair or replacement for degenerative mitral regurgitation in octogenarians. Am J Cardiol 2015; 115 (4): 487–92. doi: 10.1016/j.amjcard.2014.11.031
  10. Ware JЕ, Snow КК, Kosinski М, Gandek В. Sf-36 Health Survey. Manuel and Interpretation Guide, Lincoln, RI. Quality Metric Incorporated, 2000.
  11. Амирджанова В.Н., Горячев Д.В., Коршунов Н.И. и др. Популяционные показатели качества жизни по опроснику SF-36 (результаты многоцентрового исследования качества жизни МИРАЖ). Научно-практическая ревматология. 2008; 1: 36–48. [Amirdzhanova V.N., Goriachev D.V., Korshunov N.I. et al. Populiatsionnye pokazateli kachestva zhizni po oprosniku SF-36 (rezul’taty mnogotsentrovogo issledovaniia kachestva zhizni MIRAZh). Nauchno-prakticheskaia revmatologiia. 2008; 1: 36–48 (in Russian).]
  12. Goldsmith IR, Lip GY, Patel RL. A prospective study of changes in the quality of life of patients following mitral valve repair and replacement. Eur J Cardiothorac Surg 2001; 20 (5): 949–55.
  13. Zhao L, Kolm P, Borger MA et al. Comparison of recovery after mitral valve repair and replacement. J Thorac Cardiovasc Surg 2007; 133: 1257–63.
  14. Ay Y, Kara I, Aydin C et al. Comparison of the health related quality of life of patients following mitral valve surgicalprocedures in the 6-months follow-up: a prospective study. Ann Thorac Cardiovasc Surg 2013; 19 (2): 113–9.
  15. Goldsmith IR, Vaccarino V, Elefteriades JA et al. Health related quality of life after mitral valve repairs and replacements. Qual Life Res 2006; 15 (7): 1153–60.
  16. Immer FE, Donati O, Wyss T et al. Quality of life after mitral valve surgery: differences between reconstruction and replacement. J Heart Valve Dis 2003; 12 (2): 162–8.
  17. Jokinen JJ, Hippeläinen MJ, Pitkänen OA, Hartikainen JEK. Mitral valve replacement versus repair: propensity-adjusted survival and quality-of-life analysis. Ann Thorac Surg 2007; 84: 451–8.
  18. Falcoz PE, Chocron S, Laluc F et al. Gender analysis after elective open heart surgery: a two-year comparative study of quality of life. Ann Thorac Surg 2006; 81: 1637–43.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure: 1. QOL of patients in the long-term period by groups (normalized values for the American and Russian populations).

Download (45KB)
3. Figure: 2. QOL: physical and mental health (normalized values for the American population).

Download (10KB)

Copyright (c) 2020 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies